Harry T Byrne, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 120 Brett Chase, Suite C, Paducah, KY 42003 Phone: 888-839-1382 |
Dr. William R. Adams, Ii Ii, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4787 Alben Barkley Drive, Paducah, KY 42002 Phone: 270-442-9461 Fax: 618-441-0079 |
Robert Alan Burnett, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2320 Broadway St, Ste 400, Paducah, KY 42001 Phone: 270-444-7905 Fax: 270-444-7950 |
Dr. Stephen Stivers, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2000 Kentucky Ave, Paducah, KY 42003 Phone: 270-444-9011 Fax: 270-444-9902 |
Stivers & Stivers Psc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2000 Kentucky Ave, Paducah, KY 42003 Phone: 270-444-9011 Fax: 270-444-9902 |
Chadwick Bassi Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 2603 Kentucky Ave, Suite 105, Paducah, KY 42003 Phone: 270-415-4802 Fax: 270-415-4835 |
News Archive
Americans are increasingly resorting to stomach-shrinking surgery so much so that health experts and insurance companies are becoming alarmed about the safety issues and cost of such operations.
On Tuesday, April 9, Porter Adventist Hospital will be hosting an important community class discussing ministrokes, or transient ischemic attacks (TIA), and their connection to future stroke risk.
The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity. The FDA had previously approved 2 mg and 4 mg naloxone nasal spray products.
HIV prevention remains a public health priority in the United States. Pre-exposure prophylaxis (PrEP) is a drug regimen recommended for individuals who have engaged in behaviors that place them at elevated risk for HIV.
Using CT-scan images to steer gene-therapy injections directly into the tumor offers a safe delivery method for treating patients with metastatic kidney cancer, report UCLA radiologists in the May issue of Radiology. Their findings could enhance the treatment of the disease, which resists traditional intravenous chemotherapy in 85 percent of cases.
› Verified 2 days ago